Product Information
NAPROXEN SODIUM 220 MG TABLET is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.0669 per EA under NDC 45802049075. Its NADAC has been published 204 times since Sep 28, 2022.
FDA first approved this application on Jan 13, 1997.
Strength
220 mg/1
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802049075
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
NAPROXEN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA074661FDA Approved
1/13/1997
On Market Since
4/11/2014
Pharmacological Classes
Price Statistics
The NADAC for NAPROXEN SODIUM 220 MG TABLET has been published 204 times since Sep 28, 2022, and over the history we have for it it has risen 6.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0669 per EA |
|---|---|
| All-time high | $0.0683 (Aug 12, 2026) |
| All-time low | $0.0567 (Apr 17, 2024) |
| 52-week high | $0.0683 |
| 52-week low | $0.0635 |
| Median price | $0.0640 |
| Average price | $0.0638 |
| Largest weekly change | +10.0% (Sep 20, 2023) |
| Weeks tracked | 204 |
| Tracking since | Sep 28, 2022 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NAPROXEN SODIUM 220 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NAPROXEN SODIUM 220 MG TABLET, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.0669 per EA (NDC 45802049075), effective Aug 19, 2026.
How has the price of NAPROXEN SODIUM 220 MG TABLET changed over time?
Over the history we have for it, the NADAC for NAPROXEN SODIUM 220 MG TABLET has risen 6.0%. It has been tracked across 204 weekly CMS publications since Sep 28, 2022.
What are the highest and lowest recorded NADAC prices for NAPROXEN SODIUM 220 MG TABLET?
Since Sep 28, 2022, the NADAC for NAPROXEN SODIUM 220 MG TABLET has ranged from a low of $0.0567 (Apr 17, 2024) to a high of $0.0683 (Aug 12, 2026), with a median of $0.0640 per EA.
Are there cheaper alternatives to NAPROXEN SODIUM 220 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALL DAY PAIN RLF 220 MG CAPLET, is $0.0551 per EA — about 18% below NAPROXEN SODIUM 220 MG TABLET.
Who manufactures NAPROXEN SODIUM 220 MG TABLET?
NAPROXEN SODIUM 220 MG TABLET (NDC 45802049075) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.